S100P and breast carcinoma: Previously we have demonstrated that both S100A4 and S100P are able to promote metastasis in syngeneic rat models for breast cancer and that their overexpression in human primary breast cancers is associated with poor patient prognosis [5,9,43] due to metastasis, at least to the brain [44,45] and the liver [46].